Your browser doesn't support javascript.
loading
Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma.
Hatiboglu, Gencay; Hohenfellner, Markus; Arslan, Aysenur; Hadaschik, Boris; Teber, Dogu; Radtke, Jan Philipp; Hallscheidt, Peter; Tolstov, Yanis; Roth, Wilfried; Grüllich, Carsten; Huesing, Johannes; Duensing, Stefan; Pahernik, Sascha.
Afiliación
  • Hatiboglu G; Department of Urology, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany. gencay.hatiboglu@med.uni-heidelberg.de.
  • Hohenfellner M; Department of Urology, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
  • Arslan A; Molecular Urooncology, Department of Urology, University of Heidelberg, Heidelberg, Germany.
  • Hadaschik B; Department of Urology, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
  • Teber D; Department of Urology, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
  • Radtke JP; Department of Urology, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
  • Hallscheidt P; Department of Diagnostic and Interventional Radiology, University of Heidelberg, Heidelberg, Germany.
  • Tolstov Y; Molecular Urooncology, Department of Urology, University of Heidelberg, Heidelberg, Germany.
  • Roth W; Institute for Pathology, University of Heidelberg, Heidelberg, Germany.
  • Grüllich C; Medical Oncology, National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
  • Huesing J; Coordination Centre for Clinical Trials, University of Heidelberg, Heidelberg, Germany.
  • Duensing S; Molecular Urooncology, Department of Urology, University of Heidelberg, Heidelberg, Germany.
  • Pahernik S; Department of Urology, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Langenbecks Arch Surg ; 402(4): 637-644, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28012035
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Carcinoma de Células Renales / Niacinamida / Neoplasias Renales / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Langenbecks Arch Surg Año: 2017 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Carcinoma de Células Renales / Niacinamida / Neoplasias Renales / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Langenbecks Arch Surg Año: 2017 Tipo del documento: Article País de afiliación: Alemania